Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep neuromuscular block with hypocapnia versus normocapnia during laparoscopic renal or prostate surgery
NL-OMON38910Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Sugammadex in renal cell carcinoma (RCC) and prostate cancer (PCa) (2 arms), sponsored by Leiden University Medical Center. Started Jan 2014; status: active, not recruiting.
02
Drugs
Sugammadex
03
Conditions
renal cell carcinoma (RCC)prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON38910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38910.